drugset / Trial / NCT00266643

Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain

NCT00266643

Phase 4 Completed 205 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to compare the tolerability of different methods for switching from another medication to duloxetine for the management of diabetic nerve pain. The primary objective is to compare the most gradual method with the most abrupt method, to see if they have different tolerability.

Timeline

Start
2005-12
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule